Genotype Specific Differences In Magnitude Of HBsAg Reduction During TDF or tenofovir alfenamide (TAF) Therapy In CHB Patients

Volume
64
Pagination
918A - 918A
ISSN
0270-9139
Metadata
Show full item record
Authors
Marcellin, P; Seto, W-K; Hu, C-T; Yurdaydin, C; Foster, GR; Flaherty, JF; Kim, K; Suri, V; Gaggar, A; Subramanian, M
URI
http://qmro.qmul.ac.uk/xmlui/handle/123456789/18442
Collections